Within the framework of International R&D Nuclis call organized by ACCIÓ, Cytes Biotechnologies has been chosen as a success case for having won the grant that will promote its expansion and international growth.

For this reason, Jordi Xapelli, CEO of Cytes Biotechnologies, SL participated in a talk that took place last Friday, July 17th, where he explained the progress of the project in which the company is involved within this framework.

The aim of this talk was to promote the realization of R+D activities carried out in Catalonia and to facilitate international technological cooperation with foreign entities.

Fuente: CYTES BIOTECHNOLOGIES, SL.

https://www.cytesbiotechnologies.com/acci%C3%B3
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

Dr. Eduard Vieta: 'Después del confinam...

by Fundació Clínic per a la Recerca Biomèdica

Entrevista al Dr. Eduard Vieta, Jefe de servicio de psiquiatría y psi...

Diapositiva de Fotos